Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.

Mette Ølgod PedersenAnne Ortved GangPeter BrownMichael PedersenHelle KnudsenSigne Ledou NielsenTim PoulsenTobias Wirenfeldt KlausenEstrid HøgdallPeter Nørgaard

Published in: PloS one (2017)

In young patients with high-risk DLBCL, treatment with R-CHOEP may overcome the negative prognostic impact of DE observed in patients treated with R-CHOP.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
middle aged
electronic health record
transcription factor
combination therapy
machine learning
newly diagnosed
artificial intelligence